| Name | Title | Contact Details |
|---|---|---|
Katie Bevier |
Chief Technology Officer | Profile |
ZumePizza is the perfect marriage of food and technology; a seamless blend of art and science. Our passion for pizza has led us to reinvent every single thing about the way we deliver your food.
Fork Farms is an ag tech company that provides indoor hydroponic farming technology to social service providers and local farmers to make our food system more socially just. Their flagship product, the Flex Farm, is a fully self-contained and portable ...
Fresh Texas brings old world craftsmanship to new world applications for fresh, high quality, value added produce solutions. We work directly with our customers, building solutions that help grow their value-added produce business.
35% Vegetable and Humanely Raised Meat Sausages in Fun Flavors. Heat And Eat. Delivered Straight to Your Door With Free Nationwide Shipping.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.